Chande of fibronectin concentration in erysipelas

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The role of plasma fibronectin in hemostasis system in erysipelas, depending on the disease gravity and pronounced hemorrhagic syndrome, is studied. The results obtained indicate that different phases of disseminated intravascular blood coagulability syndrome are determined, depending directly on the disease gravity in patients with erysipelas at the height of the disease in the presence of the decrease of plasma fibronectine. The decrease of plasma fibronectine in heavy infectious disease is connected with its consumption in the process of intravascular microthrombogenesis and presents a unique protective response of the macroorganism to the action of pathogene toxins.

Full Text

Restricted Access

About the authors

V. Kh. Fazylov

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Research Institute of Experimental Cardiology VKNTS AMS RF

Author for correspondence.
Email: info@eco-vector.com
Russian Federation

E. E. Efremov

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Research Institute of Experimental Cardiology VKNTS AMS RF

Email: info@eco-vector.com
Russian Federation

G. V. Ignashenkova

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Research Institute of Experimental Cardiology VKNTS AMS RF

Email: info@eco-vector.com
Russian Federation

L. V. Kurmanova

Kazan Order of the Red Banner of Labor of the Medical Institute named after S.V. Kurashov; Research Institute of Experimental Cardiology VKNTS AMS RF

Email: info@eco-vector.com
Russian Federation

References

  1. Бокарев И. И., Щепотин В. М., ЕнаН.М. Внутрисосудистое свертывание крови.—Киев, 1989.
  2. Булатова Н. А., Одишария М. С. Казанский мед. ж.—1989.—№ 3.—С. 175—176.
  3. Кузник В. И., Васильев Н. В., Цыбикоз И. Н. Иммуногенез, гемостаз и неспецифическая резистентность организма.—М., 1989.
  4. Литвинов Р. . Казанский мед. ж.— 1984,—№ 3.—С. 203—213.
  5. Литвинов Р. . Казанский мед. ж.— 1986—№ 5.—С. 391—397.
  6. Ломазова К. Д., Полякова А. Р., Ермолин Г. А. и др. Клин. мед.—1986.—№ 3.— С. 45-47.
  7. Мороков В. Казанский мед. ж.— 1988.—№ 3.—С. 201—203.
  8. Одишария М. Казанский мед. ж.— 1987—№ 4.—С. 294—295.
  9. С амер ханов а Л. Ч., Волощук, О. М. Казанский мед. ж.—1987.—№ 3.—С. 178—182.
  10. Савченко В. Г., Васильев С. А., Ермолин Г. А. и др. Тер.арх,—1984.—№ 6.—С. 28—32.
  11. Сторожев А. Казанский мед. ж.— 1975.—№ 3.—С. 86—87.
  12. Туголуков В. Н. Унифицированные методы клинических лабораторных исследований.—М., 1974.
  13. Черкасов В. Л. Рожа.—М., 1986.
  14. Черкасов В. Л., Самотолкин К. Н., Рыскинд Р. Р. Врач дело.—1985.—№ 9.—С. НО— 112.
  15. Bidwell E. Biochem. J.—1953.—Vol. 55.— P 333.
  16. Campbell D. M. Biochem.— 1962.—Vol. 82.—P. 9—15.
  17. Cummine H., Lyons R. AL Brit. J. Surg.— 1948.—Vol. 35.—P. 140.
  18. Gilboa N., Kaplan I. E. Tromb. and Hacmost.— 1985.— Vol. 54.—P. 639—644.
  19. Grossman I. E. Rev. Infect. Dis.— 1987.— Vol. 9.— P. 420—430.
  20. Hermann Blut.— 1985.—Vol. 51.— P. 307—314.
  21. Mosher D. F. Ann. Rev. Med.— Selec. Top. Clin. Sci.— 1984.—Vol. 35.—P. 561—575.
  22. Woods D. £. Rev. Infect. Dis.— 1987.— Vol. 9.— P. 386—390.

Supplementary files

Supplementary Files
Action
1. JATS XML

© 1993 Fazylov V.K., Efremov E.E., Ignashenkova G.V., Kurmanova L.V.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies